ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases
4.9 (92) · $ 25.00 · In stock
Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint Neuro Maestro Brain Model Comparative Reproducibility Error Results Reproducibility error of Maestro (green), FreeSurfer 7.2 (blue) and manual segmentation (red) for common brain structures (left), and average over all structures (right). Bars represent range of measured relative volume difference. SOLANA BEACH, Calif., Feb. 21, 2024 (GLOBE NE
Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint
ClearPoint Neuro (CLPT): A Buy Based On Growing Revenues, Decreasing Cash Burn
ClearPointNeuro (@ClearPointNeuro) / X
Our History
ClearPoint Neuro, Inc. on LinkedIn: #clearpoint #prism #nsgy #medicaleducation #clpt
ClearPoint Neuro (CLPT) Gets FDA's Nod for New Software
CLPT - ClearPoint Neuro - by Jonah Lupton
SNN
ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model
INVESTOR INITIATIVES
SEC Filing Voyager Therapeutics Inc.
Stock Market News 2024-02-21
SNN
SNN
